Company Overview of BrainCells Inc.
BrainCells Inc. develops and provides biopharmaceutical products for the treatment of central nervous system (CNS) diseases. It develops compounds that promote the growth of new neurons for the treatment of major depressive disorder (MDD), treatment resistant depression (TRD), and potentially Alzheimer’s disease (AD). The company also builds a pipeline of clinical-stage programs to address unmet medical needs in the treatment of mood disorders, psychoses, cognition, brain repair syndromes, and other CNS disorders. The company was founded in 2003 and is based in San Diego, California.
3636 Nobel Drive
San Diego, CA 92122
Founded in 2003
858 812 7700
858 812 7630
Key Executives for BrainCells Inc.
Similar Private Companies By Industry
|TOKU-E Corporation||United States|
|bioCSL Inc.||United States|
|Apogee Technology, Inc.||United States|
|Glycomed Incorporated||United States|
|Aestus Therapeutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact BrainCells Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.